Sanofi SA SNY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 04/26/24 EDT

49.13UNCH (UNCH)

Volume

6,320

49.13

-0.23 (-0.47%)

Volume

4,003,662

52 week range

42.63 - 55.93

Open48.84
Day High49.47
Day Low48.17
Prev Close49.36
52 Week High55.93
52 Week High Date05/05/23
52 Week Low42.63
52 Week Low Date10/27/23

Key Stats

Market Cap124.288B
Shares Out2.53B
10 Day Average Volume2.83M
Dividend2.04
Dividend Yield4.15%
Beta0.60
YTD % Change-1.21

KEY STATS

Open48.84
Day High49.47
Day Low48.17
Prev Close49.36
52 Week High55.93
52 Week High Date05/05/23
52 Week Low42.63
52 Week Low Date10/27/23
Market Cap124.288B
Shares Out2.53B
10 Day Average Volume2.83M
Dividend2.04
Dividend Yield4.15%
Beta0.60
YTD % Change-1.21

RATIOS/PROFITABILITY

EPS (TTM)1.95
P/E (TTM)25.23
Fwd P/E (NTM)12.07
EBITDA (TTM)15.736B
ROE (TTM)7.26%
Revenue (TTM)50.104B
Gross Margin (TTM)68.74%
Net Margin (TTM)10.14%
Debt To Equity (MRQ)24.88%

EVENTS

Earnings Date07/25/2024(est)
Ex Div Date05/09/2024
Div Amount2.0374
Split Date-
Split Factor-

Latest On Sanofi SA

Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this yearApril 25, 2024CNBC.com
Drug similar to Ozempic slowed progression of Parkinson's disease in trialApril 4, 2024CNBC.com

Content From Our Affiliates

Kepler Capital Keeps Their Hold Rating on Sanofi (SNYNF)April 26, 2024TipRanks
DZ BANK AG Keeps Their Hold Rating on Sanofi (SNYNF)April 25, 2024TipRanks
Sanofi SA Starts 2024 with Strong Sales GrowthApril 25, 2024TipRanks
Jefferies Sticks to Its Buy Rating for Sanofi (SNYNF)April 25, 2024TipRanks
SNY Earnings: Sanofi Jumps on Healthy Q1 PerformanceApril 25, 2024TipRanks

Profile

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The...

Frederic Oudea

Independent Chairman of the Board

Paul Hudson Ph.D.

Chief Executive Officer, Executive Director, Member of the Executive Committee

Francois-Xavier Roger

Chief Financial Officer, Member of the Executive Committee

Roy Papatheodorou

Executive Vice President, General Counsel, Member of the Executive Committee

Brendan O'Callaghan

Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee

Address

46 Avenue de la Grande Armee

Paris

75017

France

https://www.sanofi.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BMY Bristol-Myers Squibb Co	44.85	+0.15	+0.34%
GSK GSK plc	41.11	+0.20	+0.49%
PFE Pfizer Inc	25.40	+0.14	+0.55%
NVS Novartis AG	97.44	-1.62	-1.64%
AMGN Amgen Inc	269.98	+0.60	+0.22%